|
|
|
|
||
Good news today; up 22 percent..0.55 cents nowBionovo Inc. (BNVI, $0.55, +$0.10, +22.54%) published encouraging results from a study of its new treatment to target and kill certain breast-cancer cells. The treatment, BN107, is meant to kill breast-cancer cells that aren't affected by levels of estrogen or progesterone in the body. This type, known as estrogen receptor negative breast cancer, accounts for about 40% of women diagnosed with breast cancers in the U.S., according to the company. |
return to message board, top of board |